CleanSpark
CLSK
MARA Holdings
MARA
Bitdeer Technologies
BTDR
4
Bakkt Holdings
BKKT
5
Canaan
CAN
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.